公开(公告)号：US08735396B2

公开(公告)日：2014-05-27

申请号：US13899851

申请日：2013-05-22

Applicant: Pfizer Inc.

Inventor： Jeffrey Allen Pfefferkorn ,  Anthony Lai Ling

IPC: A61K31/497

CPC classification number: C07D405/14

Abstract: The present invention provides compounds of Formula (I) that act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by glucokinase.

Abstract translation: 本发明提供了作为葡糖激酶活化剂的式（I）化合物; 其药物组合物; 以及治疗由葡萄糖激酶介导的疾病，病症或病症的方法。

公开(公告)号：US20130252973A1

公开(公告)日：2013-09-26

申请号：US13899851

申请日：2013-05-22

Applicant: Pfizer Inc.

Inventor： Jeffrey Allen Pfefferkorn ,  Anthony Lai Ling

IPC: C07D405/14

CPC classification number: C07D405/14

Abstract: The present invention provides compounds of Formula (I) that act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by glucokinase.

Abstract translation: 本发明提供了作为葡糖激酶活化剂的式（I）化合物; 其药物组合物; 以及治疗由葡萄糖激酶介导的疾病，病症或病症的方法。